U.S. and European Clinical Development for Asian MedTech Startups

On-demand webinar

Uncategorized
Published on:
May 6, 2022

This webinar is part of the free webinar series “Expanding Beyond APAC” launched to discuss the strategies, challenges, and best practices of entering new markets and scaling beyond the Asia Pacific for MedTech companies.  

The webinar series is prepared together with APACMed, Asia Pacific’s regional trade association which represents manufacturers and providers of medical equipment and devices, in-vitro diagnostics, digital health; as well as local associations and other key stakeholders within the medical technology industry. 

The webinar “U.S. and European Clinical Development for Asian MedTech Startups” focused on key considerations for Asian MedTech companies interested in engaging in clinical trials in these geographies. The webinar examined the clinical trial landscape in each region, including patient pathways, interactions with clinical trial sites, and key metrics related to startup timelines, trial execution timelines, and other key dates. We additionally discussed key items for consideration, including clinical trial budgets, accurate timelines, and risk mitigation strategies, including the lingering effects of COVID-19 on the clinical trial area in these geographies.

WHO SHOULD JOIN THIS WEBINAR:

MedTech, digital health and IVD startups, and Small & Medium-sized Enterprises based in the Asia Pacific planning to expand commercially to Europe and North America. 

WHAT YOU CAN LEARN:
  • What is the site startup/ethics committee process for clinical trials in these geographies
  • How to estimate trial timelines and costs for clinical trials in these geographies
  • How sponsors can interact with site Principal Investigators and study teams, including the role of CROs
  • Risk mitigation strategies and factors for clinical trials in these geographies

Meet the speakers

Chris Rao – Senior Vice President, Clinical Development, Alira Health

Christopher has 15 years of experience in clinical research, with a focus on clinical trial design and operations. As a strategist, Christopher works identifies client’s key needs early and creates tailored, targeted plans for clinical development and market success. Throughout his career, Christopher has worked closely with small-to-medium biotech and pharmaceutical oncology companies, developing novel technologies.

Kenny Carberry – Director, Clinical Development, Alira Health

Kenny Carberry

Kenny leads business development efforts and initiatives for early-stage healthcare companies in Alira Health. His background covers a wide array of indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.

Related news

Events February 2, 2023
ACDM 2023
We are pleased to announce that we will be sponsoring and attending ACDM 2023. ACDM23 offers a full two-day program of expert speakers, specialist panels, workshops and debates which(...)
Clinical Data Science
Publications February 2, 2023
Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’
In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations.
MedTech Pharma
News January 31, 2023
The Playbook for Patient Engagement in MedTech in the U.S. is Launched
The MedTech Patient Engagement Think Tank announced today the launch of the Playbook for Patient Engagement in MedTech in the U.S.
MedTech Patient Engagement
Publications January 31, 2023
A Playbook for Patient Engagement in MedTech in the U.S.
“A Playbook for Patient Engagement in MedTech in the U.S.” is a result of amalgamating ideas, research, findings, and forecasts from industry subject matter experts that together(...)
MedTech Patient Engagement
Publications January 19, 2023
Medical Device Regulation in 2023: A Window of Opportunity
We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.
Medical Devices MedTech Regulatory
Publications January 19, 2023
What’s Next for Diabetes: Patient Engagement, Personalization, and Usable Technology
Alira Health partnered with the ADA to support this conversation and explore the most important topics emerging from patients, physicians, specialists, and patient advocates including(...)
Clinical Trials Diabetes MedTech Patient Engagement
Publications January 17, 2023
Insights on the MedTech Industry
In 2023, the MedTech industry will seek to turn the challenges of disruption into opportunities for lasting transformation. Discover the three keys that a successful MedTech company(...)
Healthcare Technology MedTech Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.